CRISPR Screens to Identify Regulators of Tumor Immunity.
CRISPR Screens to Identify Regulators of Tumor Immunity.
复制标题
DOI:
10.1146/annurev-cancerbio-070120-094725
复制
发表时间:
2022-04
影响因子:
7.7
通讯作者:
Sharpe, Arlene H.
中科院分区:
文献类型:
--
作者:
LaFleur, Martin W.;Sharpe, Arlene H.
Cancer immunotherapies, such as immune checkpoint blockade (ICB), have been used in a wide range of tumor types with immense clinical benefit. However, ICB does not work in all patients, and attempts to combine ICB with other immune-based therapies have not lived up to their initial promise. Thus, there is a significant unmet need to discover new targets and combination therapies to extend the benefits of immunotherapy to more patients. Systems biology approaches are well suited for addressing this problem because these approaches enable evaluation of many gene targets simultaneously and ranking their relative importance for a phenotype of interest. As such, loss-of-function CRISPR screens are an emerging set of tools being used to prioritize gene targets for modulating pathways of interest in tumor and immune cells. This review describes the first screens performed to discover cancer immunotherapy targets and the technological advances that will enable next-generation screens.
登录
查看更多内容
影响因子:
82.9
作者:
Charlesworth, Carsten T.;Deshpande, Priyanka S.;Porteus, Matthew H.
通讯作者:
Porteus, Matthew H.
影响因子:
64.5
作者:
Dong, Matthew B.;Wang, Guangchuan;Chen, Sidi
通讯作者:
Chen, Sidi
影响因子:
15.9
作者:
Baitsch, Lukas;Baumgaertner, Petra;Speiser, Daniel E.
通讯作者:
Speiser, Daniel E.
影响因子:
32.4
作者:
DIGHE, AS;RICHARDS, E;SCHREIBER, RD
通讯作者:
SCHREIBER, RD
影响因子:
82.9
作者:
Binnewies M;Roberts EW;Kersten K;Chan V;Fearon DF;Merad M;Coussens LM;Gabrilovich DI;Ostrand-Rosenberg S;Hedrick CC;Vonderheide RH;Pittet MJ;Jain RK;Zou W;Howcroft TK;Woodhouse EC;Weinberg RA;Krummel MF
通讯作者:
Krummel MF